Cargando…
Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs
Developing a better understanding of sources and mechanisms of heterogeneity is a key route to improving outcomes and targeting of preventive interventions. This commentary attempts to draw together findings from eight intervention trials in this special issue, each exploring baseline target moderat...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938011/ https://www.ncbi.nlm.nih.gov/pubmed/36418802 http://dx.doi.org/10.1007/s11121-022-01458-1 |
_version_ | 1784890547403489280 |
---|---|
author | Gardner, Frances |
author_facet | Gardner, Frances |
author_sort | Gardner, Frances |
collection | PubMed |
description | Developing a better understanding of sources and mechanisms of heterogeneity is a key route to improving outcomes and targeting of preventive interventions. This commentary attempts to draw together findings from eight intervention trials in this special issue, each exploring baseline target moderation (BTM) or baseline target moderated mediation (BTMM). It considers their implications for prevention research and program design, particularly the question of whether they can help us to revise or adapt interventions. The studies cover a range of interventions, targets, and contexts, including parenting, couple, and CBT interventions, for depression, anxiety, conduct problems, or obesity. Some important findings stand out. Where studies found moderator effects, they tended to operate in a “compensatory” fashion, such that greater benefit was found in higher risk groups, suggesting that closer targeting might be warranted. It was rare for harmful effects to be detected for any subgroups. In other respects, patterns of BTM/BTMM findings were quite mixed across studies, suggesting it would be premature to change our interventions based on these trials. Implications of the findings for equity, for “slimming down” and scaling up interventions, and for research are discussed, including the need to combine BTMM with intervention component research, and to accumulate a more robust body of evidence by pooling data across trials. |
format | Online Article Text |
id | pubmed-9938011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-99380112023-02-19 Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs Gardner, Frances Prev Sci Article Developing a better understanding of sources and mechanisms of heterogeneity is a key route to improving outcomes and targeting of preventive interventions. This commentary attempts to draw together findings from eight intervention trials in this special issue, each exploring baseline target moderation (BTM) or baseline target moderated mediation (BTMM). It considers their implications for prevention research and program design, particularly the question of whether they can help us to revise or adapt interventions. The studies cover a range of interventions, targets, and contexts, including parenting, couple, and CBT interventions, for depression, anxiety, conduct problems, or obesity. Some important findings stand out. Where studies found moderator effects, they tended to operate in a “compensatory” fashion, such that greater benefit was found in higher risk groups, suggesting that closer targeting might be warranted. It was rare for harmful effects to be detected for any subgroups. In other respects, patterns of BTM/BTMM findings were quite mixed across studies, suggesting it would be premature to change our interventions based on these trials. Implications of the findings for equity, for “slimming down” and scaling up interventions, and for research are discussed, including the need to combine BTMM with intervention component research, and to accumulate a more robust body of evidence by pooling data across trials. Springer US 2022-11-23 2023 /pmc/articles/PMC9938011/ /pubmed/36418802 http://dx.doi.org/10.1007/s11121-022-01458-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Gardner, Frances Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs |
title | Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs |
title_full | Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs |
title_fullStr | Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs |
title_full_unstemmed | Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs |
title_short | Commentary for Special Issue on Using Baseline Target Moderation to Assess Variation in Prevention Impact: When (and How) to Revise Our Programs |
title_sort | commentary for special issue on using baseline target moderation to assess variation in prevention impact: when (and how) to revise our programs |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938011/ https://www.ncbi.nlm.nih.gov/pubmed/36418802 http://dx.doi.org/10.1007/s11121-022-01458-1 |
work_keys_str_mv | AT gardnerfrances commentaryforspecialissueonusingbaselinetargetmoderationtoassessvariationinpreventionimpactwhenandhowtoreviseourprograms |